Close this search box.

Abuse-deterrent formulations (ADF) of opioids resist crushing or dissolving for misuse, helping to curb widespread opioid abuse.

But a recent report from the Institute for Clinical and Economic Review underestimates ADFs’ value by ignoring several key benefits.

View the Graphic

Leave a Reply

Your email address will not be published. Required fields are marked *